What is Qrons's earnings per share (EPS)?

Qrons (QRON) reported diluted earnings per share of $0.00 for fiscal year 2024. This represents a 100.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Qrons Financials

QRON

Source SEC Filings (10-K/10-Q) Data as of Dec 31, 2024 Currency USD FYE December

This page shows Qrons (QRON) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 9 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial health score pending refresh

We are recalculating Qrons's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

Qrons generated $0 in revenue in fiscal year 2024.

EBITDA

N/A

Net Income

N/A

EPS (Diluted)

$0.00

YoY+100.0%

Qrons earned $0.00 per diluted share (EPS) in fiscal year 2024. This represents an increase of 100.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$659

YoY+56.9%

5Y CAGR-60.3%

Qrons held $659 in cash against $0 in long-term debt as of fiscal year 2024.

Dividends Per Share

N/A

Shares Outstanding

18M

YoY+28.9%

5Y CAGR+6.1%

Qrons had 18M shares outstanding in fiscal year 2024. This represents an increase of 28.9% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

Return on Equity

N/A

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

QRON Income Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Revenue	$0	$0	$0	$0	$0	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	$35K
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	$259K	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	$248K	N/A
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	N/A	N/A	N/A	N/A	$52K+22.2%	$43K
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	N/A	N/A	N/A	N/A	N/A	N/A
EPS (Diluted)	$0.00+100.0%	$-0.06	N/A	N/A	N/A	N/A

Metric	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23
Revenue	N/A	$0	$0	$0	N/A	$0	$0	$0
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	$0-100.0%	$15K	N/A
R&D Expenses	N/A	N/A	$58K	N/A	N/A	N/A	-$10K-242.3%	$7K
SG&A Expenses	N/A	N/A	$11K-16.1%	$13K	N/A	N/A	$14K+83.2%	$8K
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	-$23K	N/A
Interest Expense	N/A	$8K-44.8%	$14K-6.8%	$15K	N/A	$14K	N/A	$17K
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	N/A	N/A	N/A	N/A	N/A	N/A	-$13K	N/A
EPS (Diluted)	N/A	N/A	N/A	N/A	N/A	$0.00	$0.00	N/A

QRON Balance Sheet

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Total Assets	$659+56.9%	$420-86.3%	$3K-91.2%	$35K-39.2%	$58K-53.3%	$123K
Current Assets	$659+56.9%	$420-86.3%	$3K-91.2%	$35K-39.2%	$58K-53.3%	$123K
Cash & Equivalents	$659+56.9%	$420-86.3%	$3K-91.2%	$35K-39.2%	$58K-14.0%	$67K
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$446K-70.1%	$1.5M+16.1%	$1.3M+12.7%	$1.1M+51.3%	$752K+19.1%	$631K
Current Liabilities	$432K-67.3%	$1.3M+3.2%	$1.3M+12.7%	$1.1M+51.3%	$752K+19.1%	$631K
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$445K+70.1%	-$1.5M-16.3%	-$1.3M-16.0%	-$1.1M-58.8%	-$694K-36.6%	-$508K
Retained Earnings	-$10.4M-0.5%	-$10.3M-8.3%	-$9.5M-8.3%	-$8.8M-13.8%	-$7.7M-9.4%	-$7.1M

Metric	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23
Total Assets	$659-69.2%	$2K-81.7%	$12K+221.9%	$4K+766.0%	$420-94.1%	$7K+7.5%	$7K+48.1%	$4K
Current Assets	$659-69.2%	$2K-81.7%	$12K+221.9%	$4K+766.0%	$420-94.1%	$7K+7.5%	$7K+48.1%	$4K
Cash & Equivalents	$659-69.2%	$2K-81.7%	$12K+221.9%	$4K+766.0%	$420-94.1%	$7K+7.5%	$7K+48.1%	$4K
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$446K-64.7%	$1.3M+1.8%	$1.2M-15.9%	$1.5M-0.9%	$1.5M+4.5%	$1.4M+8.4%	$1.3M-2.8%	$1.4M
Current Liabilities	$432K-62.2%	$1.1M+2.3%	$1.1M-17.0%	$1.3M+1.7%	$1.3M-7.1%	$1.4M+8.4%	$1.3M-2.8%	$1.4M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$445K+64.7%	-$1.3M-2.6%	-$1.2M+16.5%	-$1.5M+1.2%	-$1.5M-5.0%	-$1.4M-8.4%	-$1.3M+2.9%	-$1.3M
Retained Earnings	-$10.4M+1.5%	-$10.5M-0.6%	-$10.5M-1.1%	-$10.4M-0.4%	-$10.3M-1.8%	-$10.1M-5.5%	-$9.6M-0.1%	-$9.6M

QRON Cash Flow Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Operating Cash Flow	N/A	N/A	N/A	-$123K+44.4%	-$220K+59.7%	-$547K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	$0	$0	$0	$0	$0	N/A
Financing Cash Flow	N/A	N/A	N/A	$100K-52.6%	$211K-55.1%	$470K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23
Operating Cash Flow	-$2K	N/A	-$12K	N/A	N/A	-$19K-27.1%	-$15K-13.0%	-$14K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	$0	$0	$0	$0	$0	$0	$0	$0
Financing Cash Flow	$1K	N/A	$20K	N/A	N/A	$20K+14.3%	$18K+16.7%	$15K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

QRON Financial Ratios

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	0.000.0	0.000.0	0.00-0.0	0.03-0.0	0.08-0.1	0.20
Debt-to-Equity	N/A	N/A	N/A	N/A	N/A	N/A
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	N/A	N/A	N/A	N/A	N/A	N/A	-191.8%	N/A
Current Ratio	0.000.0	0.000.0	0.010.0	0.000.0	0.000.0	0.010.0	0.010.0	0.00
Debt-to-Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Note: Shareholder equity is negative (-$445K), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.00), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Regen Biopharma RGBPP

Halberd Corp HALB

$637K

Evofem Bioscienc EVFM

$1.1M

Ayala Pharm ADXS

$25.7M

Frequently Asked Questions

What is Qrons's annual revenue?

Qrons (QRON) reported $0 in total revenue for fiscal year 2024. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

What are Qrons's total assets?

Qrons (QRON) had $659 in total assets as of fiscal year 2024, including both current and long-term assets.

How many shares does Qrons have outstanding?

Qrons (QRON) had 18M shares outstanding as of fiscal year 2024.

What is Qrons's current ratio?

Qrons (QRON) had a current ratio of 0.00 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.

Why is Qrons's debt-to-equity ratio negative or not reported?

Qrons (QRON) has negative shareholder equity of -$445K as of fiscal year 2024, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.